Article
Molecular markers in urologic oncology: prostate cancer.
Current opinion in urology - 1 May 2016
Reichard Chad A, Stephenson Andrew J, Klein Eric A
Abstract excerpt
PURPOSE OF REVIEW: The increased clinical availability of a wide variety of molecular tests will potentially reshape the care of both men at risk for prostate cancer and men already diagnosed. It is imperative that clinicians be familiar with indications and clinical relevance of these tests. RECENT FINDINGS: The continued clinical validation in new and expanded clinical cohorts and reports of clinical experience...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
